Securities Registration (section 12(b)) (8-a12b)
September 28 2018 - 11:20AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF
THE SECURITIES EXCHANGE ACT OF 1934
Alzheon, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
46-3074149
|
(State of incorporation
or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
111 Speen Street, Suite 306, Framingham, MA
|
|
01701
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
to be so registered
|
|
Name of each exchange on which
each class is to be registered
|
|
|
|
Common Stock, $0.001 par value per share
|
|
The Nasdaq Stock Market LLC
|
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c) or (e), check the following box. ☒
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐
If this form
relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act
registration statement or Regulation A offering statement file number to which this form relates:
333-227057
Securities to be registered pursuant
to Section 12(g) of the Act:
None
.
Item 1.
|
Description of Registrants Securities to be Registered.
|
The description of the Common Stock, par value $0.001 per share, of Alzheon, Inc. (the
Registrant
) under the heading
Description of Capital Stock in the prospectus included in the Registrants Registration Statement on Form
S-1
(File
No. 333-227057),
as initially
filed with the Securities and Exchange Commission on August 27, 2018, including exhibits, and as may be subsequently amended (the
Registration Statement
), is hereby incorporated by reference. Any form of prospectus that
constitutes part of the Registration Statement and is subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.
Pursuant to the Instructions as to Exhibits for Form
8-A,
no exhibits are required to be filed because
no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized.
Dated: September 28, 2018
|
|
|
ALZHEON, INC.
|
|
|
By:
|
|
/s/ Martin Tolar, M.D., Ph.D.
|
|
|
Martin Tolar, M.D., Ph.D.
President and
Chief Executive Officer
|
Alzheon, Inc. (MM) (NASDAQ:ALZH)
Historical Stock Chart
From Apr 2024 to May 2024
Alzheon, Inc. (MM) (NASDAQ:ALZH)
Historical Stock Chart
From May 2023 to May 2024